Ha-Neul Jeong

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 79 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Eculizumab improves fatigue in refractory generalized myasthenia gravis

Henning Andersen, Renato Mantegazza, Jing Jing Wang et al. · Quality of Life Research · 2019 · 56 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

A PPARγ-dependent miR-424/503-CD40 axis regulates inflammation mediated angiogenesis

Aram Lee, Irinna Papangeli, Youngsook Park et al. · Scientific Reports · 2017 · 41 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial

Jacqueline Palace, Dean M. Wingerchuk, Kazuo Fujihara et al. · Multiple Sclerosis and Related Disorders · 2020 · 40 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +15

Novel Glycosylated VEGF Decoy Receptor Fusion Protein, VEGF-Grab, Efficiently Suppresses Tumor Angiogenesis and Progression

Jung‐Eun Lee, Chan Kim, Hannah Yang et al. · Molecular Cancer Therapeutics · 2014 · 27 citations · Full text

Medicine, Cancer Biology, Oncology +17